TP53 wt Allele Recruiting Phase 2 Trials for Fludeoxyglucose (18F) (DB09502)

IndicationStatusPhase
DBCOND0082200 (TP53 wt Allele)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT0373235218F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients With EGFR Activated Recurrent GlioblastomaTreatment